← Open Payments lookup

JAMES GRAMLING: Open Payments

NPI 1366842015 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,763 in 97 payments from 17 companies in 2025. Trend: 2023 $1,057 · 2024 $2,038 · 2025 $1,763

Food & beverage: $1,763
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.13$275
AstraZeneca Pharmaceuticals LP12$243
PFIZER INC.12$208
Novo Nordisk Inc9$160
ABBVIE INC.11$151
Bayer Healthcare Pharmaceuticals Inc.10$151
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$113
Amgen Inc.5$91
Astellas Pharma US Inc3$77
Otsuka America Pharmaceutical, Inc.3$69

Products named: GEMTESA, Kerendia, BREZTRI, NURTEC ODT, XIFAXAN, FARXIGA, REXULTI, Veozah.

Industry payments across AL — which companies pay providers there.